Particularly, no detection of SPRY4 protein in any normal testis sample, and the profound difference of SPRY4 protein expression between moderately differentiated seminoma sample and undifferentiated seminoma sample indicate that SPRY4 may act as an oncogene in TGCT pathogenesis. Here, SPRY4 is linked to seminoma.